ReDS Pulmonary Congestion Monitoring Technology will be Showcased at Upcoming Arab Health Exhibition NETANYA, Israel, June 8, 2021 /PRNewswire/ — Sensible Medical Innovations, the market leader in medical radar monitoring and imaging technology (ReDS™) has signed a partnership with Heart Beat Medical, Dubai, UAE […]
Tag: ReDS
Medicure Announces SMILE™-HF Study Demonstrates Use of ReDS™ Results in 58% Reduction in Hospital Readmission Rate
WINNIPEG, Oct. 15, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the primary results of the late-breaking SMILETM-Heart Failure (SMILE-HF) Clinical Trial which was presented at the recent Heart Failure Society […]
Medicure Announces Launch of New and Improved ReDS™ PRO
WINNIPEG, Sept. 17, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce the launch of the ReDSTM PRO (“ReDSTM PRO”) system, the next generation of lung fluid management technology for heart failure. The debut […]
Sensible Medical announces ReDS™ Pro, the next generation of market leading lung fluid management technology for heart failure
Non-invasive monitoring technology assists in managing heart failure patients TENAFLY, N.J., Sept. 14, 2019 /PRNewswire/ — Sensible Medical Innovations today announced the launch of the ReDSTM PRO system. The debut of the new system was at the Heart Failure society of America conference in Philadelphia, […]
Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States
WINNIPEG, Jan. 28, 2019 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV:MPH,OTC: MCUJF), a cardiovascular pharmaceutical company, is pleased to announce it has entered into an agreement with Sensible Medical Innovations Inc. (“Sensible”) to become the exclusive marketing partner for the ReDS™ […]